精彩推荐
相关文章
- [APASL2014]Updates on Prevention of Mother..
- [APASL2014]Comment-Amanda Nicoll
- [APASL2014]Welcome - President
- [APASL2014]Gene Deletions and Enhanced Tum..
- [APASL2014]Prevention for Acute Exacerbati..
- [APASL2014]Entecavir for CHB: A Chinese Cl..
- [APASL2014]Racial Analysis from GIDEON
- [APASL2014]Schizophrenia Correlates with I..
- [APASL2014]State of Play:New Tools for Hep..
- [APASL2014]Debate:Does Interferon Still Ha..
- [APASL2014]Acupuncture for Treatment of Li..
- [APASL2014]The role of Sorafenib and other..
- [APASL2014]Next generation sequencing in H..
- [APASL2014]Management of Primary Sclerosin..
相关幻灯
- [APASL2014]会议亮点:乙型肝炎
- [FLD2013]PIVENS及其相关的后续研究——NAFLD治..
- [EASL2012]NAFLD背景下HCC的新影响
- [EASL2012]酒精性肝病患者的肝细胞肝癌有什么..
- [DICID2011]丙型肝炎药物遗传学
- [DICID2011]IL28B基因变异与慢性丙型肝炎患者..
- [APASL2011]HBsAg 在核苷(酸)类似物对比免疫..
- [APASL2011]Predictive Value of HBsAg in NA..
- [AASLD2010]Telaprevir联合PEG-IFN α-2a和利..
- 关于接受每天泰诺扶韦300mg慢性乙肝病毒感染..
- Case presentation: Chronic Hepatitis B
- Management of Refractory Variceal Bleeding..
- Pentoxifylline减少晚期肝硬化患者并发症的发..
- HCC治疗中的阿霉素洗脱微粒与常规化疗栓塞(c-..